Core Viewpoint - The company has received production registration approvals from the National Medical Products Administration of China for two pharmaceutical products, enhancing its portfolio in the ophthalmic and gastrointestinal preparation sectors [1] Group 1: Product Approvals - The company obtained a production registration for Levofloxacin Eye Drops (0.488% in 5ml, containing 24.4mg), classified as a Class 4 chemical drug, which is considered to have passed the consistency evaluation. This product is primarily used for treating various eye conditions such as blepharitis, conjunctivitis, and for sterile chemotherapy during ophthalmic surgeries [1] - The company also received approval for Compound Magnesium Sulfate Granules (10mg per bag), classified as a Class 3 chemical drug, which is also considered to have passed the consistency evaluation. This product is mainly used for bowel cleansing prior to colonoscopy and X-ray examinations, as well as for bowel preparation before surgical procedures [1] Group 2: Raw Material Approval - The company's magnesium sulfate raw material has been approved by the National Medical Products Administration for use in its registered formulations, indicating a solid foundation for its product offerings in the market [1]
石四药集团(02005.HK)左氧氟沙星滴眼液取得药品生产注册批件